Unveiling the uncommon: invasive adenocarcinoma cervix presenting during pregnancy: a rare case report

Sheral R. Tauro; Yanglem A. Singh; Basanti Namoijam

doi:10.18203/2320-1770.ijrcog20240817

Authors

Sheral R. Tauro Department of Obstetrics and Gynaecology, Regional Institute of Medical Sciences, Imphal, Manipur, India
Yanglem A. Singh Department of Obstetrics and Gynaecology, Regional Institute of Medical Sciences, Imphal, Manipur, India https://orcid.org/0000-0003-4603-0064
Basanti Namoijam Department of Obstetrics and Gynaecology, Regional Institute of Medical Sciences, Imphal, Manipur, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20240817

Keywords:

Adenocarcinoma cervix, Intrauterine pregnancy with cancer, Human papillomavirus

Abstract

Adenocarcinoma of the cervix presenting during pregnancy is an exceedingly rare occurrence, and the optimal management approach remains uncertain due to limited reported cases. Here we are presenting a case of a multiparous lady who presented with complaints of amenorrhoea for 3 months, pain abdomen, spotting per vaginum, mass felt per vaginum. Ultrasonography showed single live intrauterine pregnancy at 11 weeks 4 days of gestational age with an ill-defined hyperechoic lesion measuring 4.36×4.92×4.16 cm in cervix. HPE of cervical biopsy confirmed cervical adenocarcinoma-endocervical type, grade 2. On MRI, a heterogeneous exophytic irregular mass involving the external os, protruding into the upper vaginal cavity was identified with infiltration into the anterior upper vaginal wall, pelvic lymphadenopathy, and sub-centimetric inguinal lymph nodes were observed. The patient underwent radical hysterectomy with bilateral pelvic lymph node dissection. The surgical specimen exhibited stromal invasion exceeding 5mm in depth and width greater than 7mm, involving entire cervical wall with lympho-vascular space invasion. The tumor was ER/PR negative, strongly positive for P16, and HPV studies were also positive. Adjuvant external beam radiotherapy (EBRT) was administered to the pelvis, and the patient is currently in remission.

Metrics

Metrics Loading ...

References

Nguyen C, Montz FJ, Bristow RE. Management of stage I cervical cancer in pregnancy. Obstet Gynecol Surv. 2000;55(10):633.

Creasman WT. Cancer and pregnancy. Ann N Y Acad Sci. 2001;943:281.

Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001;184(7):1504.

Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189(4):1128.

Demeter A, Sziller I, Csapó Z. Outcome of pregnancies after cold‐knife conization of the uterine cervix during pregnancy. Eur J Gynaecol Oncol. 2002;23(3):207.

Duggan B, Muderspach LI, Roman LD, Curtin JP, D'Ablaing G, Morrow CP. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol. 1993;82(4-1):598.

Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol 2019;30(10):1601-12.

Shiping Z, Lushan ZQ. Progress in diagnosis and treatment of pregnancy complicated with cervical cancer. J Pract Med. 2018;25(4):400‐2.

Meihao OG. The effect of pregnancy with cervical cancer on mother and child and the principle of diagnosis and treatment. Adv Modern Obstetr Gynecol. 2008;17(1):64‐6.

Morice P, Uzan C, Gouy S, Claire V, Haie-Meder C. Gynaecological cancers in pregnancy. Lancet 2012;379(9815):558-69.

Morimura Y, Fujimori K, Soeda S, Toshihiro H, Yoshimasa T, Hidekazu Y, et al. Cervical cytology during pregnancy: comparison with non‐pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci. 2002;48(1):27‐37.

Jain AG, Higgins RV, Boyle MJ. Management of low‐grade squamous intraepithelial lesions during pregnancy. Am J Obstet Gynecol. 1997;177(2):298‐302.

Schaefer K, Peters D, Aulmann S, Sohn C, Eichbaum M. Value and feasibility of LLETZ procedures for pregnant women with suspected high‐grade squamous intraepithelial lesions and microinvasive cervical cancer. Int J Gynaecol Obstet. 2012;118(2):141‐4.

Maggen C, Wolters V, Cardonick E, Monica F, Michael JH, Christianne AR, et al. International Network on Cancer, Infertility and Pregnancy (INCIP): pregnancy and cancer: the INCIP project. Curr Oncol Rep 2020;22(2):17.

Calsteren KV, Verbesselt R, Devlieger R, De Catte L, Chai DC, Van Bree R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer. 2010;20(9):1456‐64.

Köhler C, Oppelt P, Favero G, Bernd M, Ingo R, Audrey T, et al. How much platinum passes the placental barrier analysis of platinum applications in 21 patients with cervical cancer during pregnancy. Am J Obstet Gynecol. 2015;213(2):206.e1‐5.

Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283‐91.

Furukawa S, Hayashi S, Usuda K, Abe M, Hagio S, Ogawa I. Effect of cisplatin on rat placenta development. Exp Toxicol Pathol. 2013;65(1/2):211‐7.

Kozuki N, Lee AC, Katz J, Child Health Epidemiology Reference Group. Moderate to severe, but not mild, maternal anemia is associated with increased risk of small‐for‐gestational‐age outcomes. J Nutr. 2012;142(2):358‐62.